Plunkett Research Online: Adaptive Biotechnologies Corporation

ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection an.....



Adaptive Biotechnologies Corporation
Ticker: ADPT
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 206 659-0067
Fax: 206 659-0667
Address: 1165 Eastlake Avenue East
Seattle, WA 98109 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

In-Vitro Diagnostic Substance Manufacturing
Immune System Assay
Cell Sequencing
Cell Monitoring
Contacts Description
Chad RobinsCEO/Chairman of the Board/Co-Founder/Director
Tycho PetersonCFO
See More
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection an.....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
immunoSEQ
clonoSEQ
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: